Amylyx Pharmaceuticals (AMLX) Retained Earnings (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) recorded quarterly Retained Earnings of $240000.0 in Q1 2026, down 40.59% quarter-over-quarter from $404000.0 in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Retained Earnings (2021 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Retained Earnings history runs 6 years deep, the most recent figure standing at $240000.0 for Q1 2026.
- In Q1 2026, Retained Earnings changed N/A year-over-year to $240000.0; the TTM figure through Mar 2026 stood at $240000.0 (changed N/A YoY), while the FY2025 annual figure was $404000.0, up 100.07% from the prior year.
- Retained Earnings was $240000.0 for Q1 2026 at Amylyx Pharmaceuticals, down from $404000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $404000.0 in Q4 2025 to a low of -$718.4 million in Q3 2025.
- Historically, Retained Earnings has averaged -$233.3 million across 5 years, with a median of -$101.9 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings jumped 329.07% in 2023, then tumbled 705097.94% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$86000.0 in 2022, then surged by 329.07% to $197000.0 in 2023, then slumped by 308065.48% to -$606.7 million in 2024, then soared by 100.07% to $404000.0 in 2025, then plunged by 40.59% to $240000.0 in 2026.
- The last three Retained Earnings figures came in at $240000.0 (Q1 2026), $404000.0 (Q4 2025), and -$718.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Amylyx Pharmaceuticals | 1.51 Bn | 1.51 Bn | - | 240,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240,000.00 |
| Dec 31, 2025 | 404,000.00 |
| Sep 30, 2025 | -718.43 Mn |
| Jun 30, 2025 | -684.04 Mn |
| Dec 31, 2024 | -606.69 Mn |
| Sep 30, 2024 | -569.15 Mn |
| Jun 30, 2024 | -97,000.00 |
| Mar 31, 2024 | -77,000.00 |
| Dec 31, 2023 | 197,000.00 |
| Sep 30, 2023 | -309.68 Mn |
| Jun 30, 2023 | -330.57 Mn |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | -86,000.00 |
| Sep 30, 2022 | -311.52 Mn |
| Jun 30, 2022 | -196,000.00 |
| Mar 31, 2022 | -203.69 Mn |
| Dec 31, 2021 | -155.85 Mn |